Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omacor for IgA Nephropathy
NCT00549692Phase 3Completed
- Sponsor
- Kuhnil Pharmaceutical
- Start
- Nov 2007
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of omega-3-acid triglycerides in IgA nephropathy (IgAN), sponsored by Kuhnil Pharmaceutical. Started Nov 2007; status: completed.
02
Drugs
omega-3-acid triglycerides
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on NCT00549692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00549692.